Stephen Willey
Stock Analyst at Stifel
(2.09)
# 2,797
Out of 4,843 analysts
134
Total ratings
33.68%
Success rate
-3.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.38 | +262.32% | 3 | May 14, 2025 | |
| EXEL Exelixis | Maintains: Hold | $36 → $38 | $43.04 | -11.71% | 18 | May 14, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $1.25 → $1 | $0.31 | +217.86% | 4 | May 13, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $36 → $35 | $10.63 | +229.26% | 5 | Apr 9, 2025 | |
| NKTX Nkarta | Maintains: Buy | $15 → $14 | $1.74 | +704.60% | 3 | Mar 27, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $12 → $5 | $0.20 | +2,401.25% | 5 | Mar 21, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $12 → $10 | $2.02 | +395.05% | 5 | Feb 28, 2025 | |
| GERN Geron | Maintains: Buy | $8 → $4 | $1.52 | +163.16% | 3 | Feb 27, 2025 | |
| INSM Insmed | Maintains: Buy | $97 → $96 | $69.73 | +37.67% | 6 | Feb 21, 2025 | |
| INCY Incyte | Maintains: Hold | $75 → $77 | $65.06 | +18.35% | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $27 → $2.5 | $1.27 | +96.85% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $120 | $3.40 | +3,429.41% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $11.43 | +144.97% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $9.25 | +408.11% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.63 | +531.81% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $1.86 | +61.29% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $2.24 | +212.51% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.47 | +172.11% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $28.85 | +114.90% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.10 | +328.57% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.27 | +844.88% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.00 | +14,300.00% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.50 | +740.00% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $0.63 | +538.37% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $304.56 | -59.61% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $33.51 | +40.26% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $58.07 | +87.70% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $19.57 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $0.21 | +11,810.43% | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $6.60 | +248.48% | 5 | Feb 7, 2018 |
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.38
Upside: +262.32%
Exelixis
May 14, 2025
Maintains: Hold
Price Target: $36 → $38
Current: $43.04
Upside: -11.71%
Bolt Biotherapeutics
May 13, 2025
Maintains: Hold
Price Target: $1.25 → $1
Current: $0.31
Upside: +217.86%
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $10.63
Upside: +229.26%
Nkarta
Mar 27, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $1.74
Upside: +704.60%
Vor Biopharma
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $0.20
Upside: +2,401.25%
AbCellera Biologics
Feb 28, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.02
Upside: +395.05%
Geron
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.52
Upside: +163.16%
Insmed
Feb 21, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $69.73
Upside: +37.67%
Incyte
Feb 10, 2025
Maintains: Hold
Price Target: $75 → $77
Current: $65.06
Upside: +18.35%
Jan 10, 2025
Downgrades: Hold
Price Target: $27 → $2.5
Current: $1.27
Upside: +96.85%
Nov 14, 2024
Maintains: Buy
Price Target: $150 → $120
Current: $3.40
Upside: +3,429.41%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $11.43
Upside: +144.97%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $9.25
Upside: +408.11%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.63
Upside: +531.81%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.86
Upside: +61.29%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.24
Upside: +212.51%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.47
Upside: +172.11%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $28.85
Upside: +114.90%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $2.10
Upside: +328.57%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.27
Upside: +844.88%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.00
Upside: +14,300.00%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.50
Upside: +740.00%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $0.63
Upside: +538.37%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $304.56
Upside: -59.61%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $33.51
Upside: +40.26%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $58.07
Upside: +87.70%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $19.57
Upside: -
Mar 7, 2018
Maintains: Buy
Price Target: $23 → $25
Current: $0.21
Upside: +11,810.43%
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $6.60
Upside: +248.48%